Praveen Sridhar

P1.020. Real-World Deviations From Standard Adjuvant Immunotherapy After Esophagectomy

Abstract Topic Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Background Adjuvant IO is recommended within 4–16 weeks post-esophagectomy, but delays and interruptions are common in practice. Trials like CheckMate 577 permitted treatment delays of up to 10 weeks. We evalua...